Guidance
5 Diagnostics advisory committee members and NICE project team
Committee members
This topic was considered by the diagnostics advisory committee, which is a standing advisory committee of NICE.
Committee members are asked to declare any interests in the test to be evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.
The minutes of each committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.
Additional specialist committee members took part in the discussions for this topic:
Specialist committee members
Daniel Burrage
Consultant in clinical pharmacology, St George's University Hospitals NHS Foundation Trust
Mark Cadman
Specialist lay committee member
Alexander Doney
Senior clinical lecturer and honorary consultant physician, University of Dundee
Salim Elyas
Consultant stroke physician, University of Exeter and Royal Devon University Healthcare NHS Foundation Trust
Albert Ferro
Professor of cardiovascular clinical pharmacology, King's College London
Dheeraj Kalladka
Consultant neurologist and stroke physician, Imperial College London
Dagan Lonsdale
Senior lecturer in clinical pharmacology and honorary consultant intensivist, St George's, University of London
Paresh Parmar
Lead pharmacist for stroke and older people, Northwick Park Hospital, London North West University Healthcare NHS Trust
Michelle Wood
Principal clinical scientist, All Wales Medical Genomics Service, University Hospital of Wales
NICE project team
Each diagnostics evaluation is assigned to a team consisting of a technical analyst (who acts as the topic lead), a technical adviser and a project manager.
Simon Webster and Jacob Grant
Topic leads
Thomas Walker
Technical adviser
Harriet Wilson and Donna Barnes
Project managers
ISBN: 978-1-4731-6184-9